BPC-157 Shows Consistent Fistula Healing in Rat Studies Across Multiple Organ Systems
BPC-157, a stable gastric pentadecapeptide, demonstrated consistent fistula healing across multiple organ systems in rat models, acting as a novel mediator of Robert's cytoprotection.
Quick Facts
What This Study Found
BPC-157 consistently promoted fistula healing in rat models across multiple organ systems, with effects linked to its anti-ulcer, cytoprotective, and wound-healing properties as a native gastric peptide.
Key Numbers
6+ external fistula types; internal fistulas (colovesical, rectovaginal); 7 anastomosis types; no LD1 found; stable in gastric juice >24h
How They Did This
Literature review of BPC-157 studies in rat fistula models, covering gastrointestinal and other organ system fistulas, mechanism of action, and connection to cytoprotection.
Why This Research Matters
Fistulas are serious surgical complications often resistant to treatment. If BPC-157's consistent rat results translate to humans, it could offer a non-surgical fistula healing approach.
The Bigger Picture
BPC-157's fistula healing extends its already broad wound-healing profile (tendons, muscles, gut ulcers) and supports its proposed role as a fundamental tissue repair mediator.
What This Study Doesn't Tell Us
All data from rat models — no human fistula healing trials. BPC-157 is not FDA-approved. Mechanisms remain partially understood. Review from researchers heavily involved in BPC-157 research.
Questions This Raises
- ?Would BPC-157 heal fistulas in humans, particularly Crohn's fistulas?
- ?What is the optimal route and dose for fistula-specific BPC-157 therapy?
- ?How does BPC-157 fistula healing compare to existing surgical and biologic treatments?
Trust & Context
- Key Stat:
- Consistent healing across organs BPC-157 healed fistulas in rat models across gastrointestinal and other organ systems
- Evidence Grade:
- Preliminary — consistent rat results but no human clinical data for fistula healing specifically.
- Study Age:
- Published in 2020; BPC-157 remains widely discussed in both research and peptide supplement communities.
- Original Title:
- Fistulas Healing. Stable Gastric Pentadecapeptide BPC 157 Therapy.
- Published In:
- Current pharmaceutical design, 26(25), 2991-3000 (2020)
- Authors:
- Sikiric, Predrag(44), Drmic, Domagoj(20), Sever, Marko(18), Klicek, Robert, Blagaic, Alenka B, Tvrdeic, Ante, Kralj, Tamara, Kovac, Katarina K, Vukojevic, Jaksa, Siroglavic, Marko, Gojkovic, Slaven, Krezic, Ivan, Pavlov, Katarina H, Rasic, Domagoj, Mirkovic, Ivan, Kokot, Antonio, Skrtic, Anita, Seiwerth, Sven
- Database ID:
- RPEP-05137
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What is a fistula and why is it hard to treat?
A fistula is an abnormal tunnel between two body surfaces or organs, often caused by surgery, injury, or disease like Crohn's. They often resist healing because of ongoing infection, poor blood supply, and the continuous passage of bodily fluids through the tract.
Is BPC-157 available for fistula treatment?
BPC-157 is not FDA-approved for any medical condition. While rat studies show consistent fistula healing, human clinical trials have not been conducted specifically for this application.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05137APA
Sikiric, Predrag; Drmic, Domagoj; Sever, Marko; Klicek, Robert; Blagaic, Alenka B; Tvrdeic, Ante; Kralj, Tamara; Kovac, Katarina K; Vukojevic, Jaksa; Siroglavic, Marko; Gojkovic, Slaven; Krezic, Ivan; Pavlov, Katarina H; Rasic, Domagoj; Mirkovic, Ivan; Kokot, Antonio; Skrtic, Anita; Seiwerth, Sven. (2020). Fistulas Healing. Stable Gastric Pentadecapeptide BPC 157 Therapy.. Current pharmaceutical design, 26(25), 2991-3000. https://doi.org/10.2174/1381612826666200424180139
MLA
Sikiric, Predrag, et al. "Fistulas Healing. Stable Gastric Pentadecapeptide BPC 157 Therapy.." Current pharmaceutical design, 2020. https://doi.org/10.2174/1381612826666200424180139
RethinkPeptides
RethinkPeptides Research Database. "Fistulas Healing. Stable Gastric Pentadecapeptide BPC 157 Th..." RPEP-05137. Retrieved from https://rethinkpeptides.com/research/sikiric-2020-fistulas-healing-stable-gastric
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.